BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 277247)

  • 1. The response of human tumour metastases to radiation and misonidazole.
    Dawen PJ; Peckham MJ; Steel GG
    Br J Cancer Suppl; 1978 Jun; 3():290-6. PubMed ID: 277247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW; Kochanski K
    Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
    [No Abstract]   [Full Text] [Related]  

  • 3. The optimum regime for the administration of misonidazole and the establishment of multi-centre clinical trials.
    Dische S; Saunders MI; Flockhart IR
    Br J Cancer Suppl; 1978 Jun; 3():318-21. PubMed ID: 209811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y; Murayama C; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.
    Saunders ME; Dische S; Anderson P; Flockhart IR
    Br J Cancer Suppl; 1978 Jun; 3():268-70. PubMed ID: 209808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quantitative response of human tumours to radiation and misonidazole.
    Ash DV; Peckham MJ; Steel GG
    Br J Cancer; 1979 Dec; 40(6):883-9. PubMed ID: 526430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on radiotherapy in combination with misonidazole].
    Ono K; Takahashi M; Dodo Y; Abe M
    Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1189-99. PubMed ID: 6663172
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of radiosensitization in Lewis lung carcinoma and a murine plasmacytoma by MTDQ and MTDQ-DA.
    Schlappack OK; Peacock JH; Haslinger RK; Schmidt WF; Eady JJ
    Strahlenther Onkol; 1988 Nov; 164(11):684-8. PubMed ID: 3201385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further clinical experiences of a phase I study with the hypoxic cell radiosensitizer misonidazole.
    Kogelnik HD; Meyer JH; Jentzsch K; Szepesi T; Kärcher KH; Maida E; Mamoli B; Wessely P; Zaunbauer F
    Br J Cancer Suppl; 1978 Jun; 3():281-5. PubMed ID: 209810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.
    Thomlinson RH; Dische S; Gray AJ; Errington LM
    Clin Radiol; 1976 Apr; 27(2):167-74. PubMed ID: 776494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth delay studies in patients with multiple metastases.
    Ash DV
    Br J Cancer Suppl; 1980 Apr; 4():17-20. PubMed ID: 6932924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present status of hypoxic cell sensitizers and PLDR inhibitors].
    Ono K; Sasai K; Shibamoto Y; Tsutsui K; Fushiki M; Nishidai T; Takahashi M; Abe M
    Gan No Rinsho; 1987 Oct; 33(13):1673-8. PubMed ID: 2961900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
    Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
    Hampel N; Persky L
    Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postirradiation modification of tumor blood flow: a method to increase the effectiveness of chemical radiosensitizers.
    Chaplin DJ
    Radiat Res; 1988 Aug; 115(2):292-302. PubMed ID: 3406369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with misonidazole.
    Dische S; Saunders MI
    Br J Cancer Suppl; 1978 Jun; 3():311-3. PubMed ID: 277252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin rashes associated with the administration of the 2-nitroimidazole, misonidazole.
    Saunders MI; Dische S; Kogelnik HD; Sealy R; Lenox-Smith I
    Cancer Treat Rep; 1980; 64(2-3):263-8. PubMed ID: 6447539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
    Awwad HK; El Merzabani MM; El Badawy S; Ezzat S; Akoush H; Abd El Moneim H; Saiid A; Soliman O; Khafagy M; Burgers MV
    Cancer Clin Trials; 1980; 3(3):275-80. PubMed ID: 7438324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vivo investigation of the radiosensitization of metastases by nitroimidazoles.
    Davies BM; Watling DC
    Int J Radiat Oncol Biol Phys; 1978; 4(9-10):809-19. PubMed ID: 711550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.